摘要
①目的观察γ干扰素氧驱动雾化吸入辅助治疗毛细支气管炎的临床效果。②方法将92例毛细支气管炎病儿随机分为治疗组和对照组,两组除均给予规范治疗外,对照组采用α糜蛋白酶及地塞米松加入生理盐水中氧驱动雾化吸入,治疗组则在对照组治疗基础上加γ干扰素氧驱动雾化吸入。③结果治疗组疗效明显优于对照组,差异有显著性(uc=2.51,P<0.05)。④结论γ干扰素氧驱动雾化吸入辅助治疗毛细支气管炎的临床效果良好。
Objective To investigate the effectiveness of O2 driving nebulizied interferon gamma on virus bronchiolitis. Methods Ninety-two infants admitted to hospital with bronehiolitis were randomized into two groups： 52 were allocated to receive interferon-gamma and 40 were given alpha-chymar and oradexon with O2 driving nebulizers. Results The effect was significantly different between the two groups （uc=2.51 ,P〈0.05）. Conclusion Interferon-gamma by O2 driving nebulizers may be an effective adjunctive therapy for viral bronehiolitis.
出处
《齐鲁医学杂志》
2005年第6期514-515,共2页
Medical Journal of Qilu
关键词
干扰素-γ
重组
雾化器和汽化器
支气管炎
interferon-gamma, recombinant
nebulizers and vaporizers
bronchitis
